Cancer

GLP-1RAs were associated with a significantly reduced risk of obesity-associated cancers including gallbladder cancer, pancreatic cancer, and meningioma.

DDW 2024. An investigational blood-based screening test demonstrated nearly a 80% sensitivity for detecting CRC, according to a large prospective study.

DDW 24. Among patients aged 15 to 19 years, the incidence of CRC rose 333% over a 22-year period, researchers reported.

Your daily dose of the clinical news you may have missed.

In average-risk individuals, the at-home ColoSense test demonstrated 93% sensitivity for detecting CRC and 45% sensitivity for detecting advanced adenomas.

The quality performance measure is viable and reliable and could help improve early CRC detection rates via timely colonoscopy following abnormal stool-based test.

Cologuard Plus bests previous iteration and demonstrates greater sensitivity and specificity for any CRC relative to fecal immunochemical tests.

Your daily dose of the clinical news you may have missed.

Preventive health screenings have yet to rebound to pre-COVID-19 levels and Asian adults appear to have fallen behind more than other racial/ethnic groups, a new study finds.

Over 4 million cancer deaths have been reverted since 1991, but new cancer cases are estimated to reach over 2 million, according to new data from an annual American Cancer Society report.

Data from recent Austrian study suggest that sex should be considered when determining screening age for colorectal cancer, reported authors.

Your daily dose of the clinical news you may have missed.

Early CT screening led to a 20-year lung cancer survival rate of 81% in the International Early Lung Cancer Action Program. Details, here.

To close this series, experts explore the challenges and guideline gaps in multi-cancer early detection while considering its potential impact on patient care, accessibility, and improved outcomes.

Experts explore strategies for efficient patient care coordination through early cancer detection, highlighting cost challenges while ensuring timely diagnoses and treatments.

Mylynda Massart, MD, PhD, nuances of blood-based screening (BBS) in early cancer detection and how doctors can respond to various results.

Your daily dose of the clinical news you may have missed.

Experts delve into the complexities of cancer screening, from identifying high-risk individuals to counseling patients about the nuances of screening tests, all while aiming for early detection and improved outcomes.

Experts discuss the transition from evidence-based medicine to precision medicine in the context of cancer screening, emphasizing the urgency of implementing multi-cancer screening for broad positive outcomes.

A pivotal phase 3 clinical trial showed Cologuard significantly more likely than FIT to detect cancerous and advanced precancerous lesions.

Experts discuss the evolving landscape of multicancer early detection tests, including those in development and currently available.

Experts discuss the emerging landscape of multicancer early detection testing through liquid biopsy, highlighting its potential to revolutionize cancer screening.

Candace Westgate, DO, MPH, FACOG, and Mylynda Massart, MD, PhD, introduce this series on early cancer detection, multi-cancer detection tests, and the role of primary care physicians (PCPs) in preventative care.

Candace Westgate, DO, MPH, FACOG, and Mylynda Massart, MD, PhD, introduce this series on early cancer detection, multi-cancer detection tests, and the role of primary care physicians (PCPs) in preventative care.

Get a quick look at the US worst states for health care ranked using a composite score that included measures of cost, access, and outcomes.

The best states for health care were ranked using a composite score that included measures of cost, access, and outcomes. So, which state retains the most residents?

Sales of e-cigarettes in the US jumped by 46% from 2020-2022; rapid market shifts beg coordinated restrictions to protect public health, says the CDC.

Reduced risk for 10 different cancers was reported among patients with diabetes treated with SGLT2 inhibitors compared with those not treated.

Medicinal cannabis products reduced use of opioids and other medications and products that contained balanced measures of THC and CBD appeared most effective.